Cargando…

Role of the Radiotherapy Boost on Local Control in Ductal Carcinoma In Situ

Ductal carcinoma in situ of the breast is associated with low mortality rates, but local relapse is a matter of concern in this disease. Risk factors for local relapse include young age, close or positive margins, and tumor necrosis. Whole breast irradiation following breast-conserving surgery for d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riou, Olivier, Lemanski, Claire, Guillaumon, Vanessa, Lauche, Olivier, Fenoglietto, Pascal, Dubois, Jean-Bernard, Azria, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332211/ https://www.ncbi.nlm.nih.gov/pubmed/22577533 http://dx.doi.org/10.1155/2012/748196

Ejemplares similares

Simultaneous integrated boost plan comparison of volumetric‐modulated arc therapy and sliding window intensity‐modulated radiotherapy for whole pelvis irradiation of locally advanced prostate cancer
por: Riou, Olivier, et al.
Publicado: (2013)

Feasibility of accelerated partial breast irradiation with volumetric-modulated arc therapy in elderly and frail patients
por: Riou, Olivier, et al.
Publicado: (2015)

Eight years of IMRT quality assurance with ionization chambers and film dosimetry: experience of the montpellier comprehensive cancer center
por: Fenoglietto, Pascal, et al.
Publicado: (2011)

IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center
por: Vieillot, Sabine, et al.
Publicado: (2012)

Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans
por: Menkarios, Cathy, et al.
Publicado: (2007)

Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial
por: Lemanski, Claire, et al.
Publicado: (2013)

Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy
por: Prunaretty, Jessica, et al.
Publicado: (2023)

Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer
por: Serre, Antoine, et al.
Publicado: (2007)

Bilateral kidney preservation by volumetric-modulated arc therapy (RapidArc) compared to conventional radiation therapy (3D-CRT) in pancreatic and bile duct malignancies
por: Vieillot, Sabine, et al.
Publicado: (2011)

Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer
por: Vieillot, Sabine, et al.
Publicado: (2010)

Three Years of Salvage IMRT for Prostate Cancer: Results of the Montpellier Cancer Center
por: Riou, Olivier, et al.
Publicado: (2012)

Management of the Axilla in the Era of Breast Cancer Heterogeneity
por: de Meric de Bellefon, Maïlys, et al.
Publicado: (2018)

Implementation of the Calypso system: a commissioning experience
por: Prunaretty, Jessica, et al.
Publicado: (2023)

Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial()
por: Azria, David, et al.
Publicado: (2015)

Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular Carcinoma
por: Cantaloube, Marie, et al.
Publicado: (2021)

Significance of boost radiotherapy in early invasive ductal breast cancer with ductal carcinoma in situ component under negative surgical margins
por: Shimizu, Naoko, et al.
Publicado: (2021)

Efficacy, safety, and feasibility of volumetric modulated arc therapy for synchronous bilateral breast cancer management
por: Quesada, Stanislas, et al.
Publicado: (2022)

Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience
por: Cutuli, B, et al.
Publicado: (2009)

Magnetic Resonance–Guided Reirradiation for Local Recurrence Within the Prostate or in the Prostate Bed: Preliminary Results of a Prospective Registry Study
por: Michalet, Morgan, et al.
Publicado: (2021)

Integrating respiratory-gated PET-based target volume delineation in liver SBRT planning, a pilot study
por: Riou, Olivier, et al.
Publicado: (2014)

Locoregional Control Benefit of a Tumor Bed Boost for Ductal Carcinoma In Situ
por: Dreyfuss, Alexandra D., et al.
Publicado: (2023)

Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer
por: Azria, David, et al.
Publicado: (2005)

Feasibility study of adaptive radiotherapy with Ethos for breast cancer
por: Galand, Arthur, et al.
Publicado: (2023)

Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial
por: Bourgier, Céline, et al.
Publicado: (2018)

Treatment results in patients with ductal carcinoma in situ treated with adjuvant radiotherapy
por: GÜZELÖZ, Zeliha, et al.
Publicado: (2019)

Magnetic Resonance-Guided Reirradiation for Local Recurrence within the Prostate or in the Prostate Bed: One-Year Clinical Results of a Prospective Registry Study
por: Michalet, Morgan, et al.
Publicado: (2022)

Radiotherapy after Conservative Surgery in Ductal Carcinoma In Situ of the Breast: A Review
por: Amichetti, Maurizio, et al.
Publicado: (2012)

Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy
por: Giannakeas, Vasily, et al.
Publicado: (2018)

Breathing adapted radiotherapy: a 4D gating software for lung cancer
por: Peguret, Nicolas, et al.
Publicado: (2011)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012)

Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012)

Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study
por: Michalet, Morgan, et al.
Publicado: (2022)

The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ.
por: Holland, P. A., et al.
Publicado: (1998)

Is radiotherapy necessary for intermediate risk ductal carcinoma in situ after breast conserving surgery?
por: Kim, Taeryung, et al.
Publicado: (2014)

Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study
por: Bordeau, Karl, et al.
Publicado: (2023)

Feasibility study of volumetric modulated arc therapy for the treatment of retroperitoneal sarcomas
por: Llacer-Moscardo, Carmen, et al.
Publicado: (2010)

Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results
por: Michalet, Morgan, et al.
Publicado: (2022)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry Study
por: Bordeau, Karl, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hir279t50gpei3fjeb02mtm59a